Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) — Financial Flexibility Index

Latest as of December 2024: 1.22x

Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Financial Flexibility Index of 1.22x as of December 2024. Free cash flow of CN¥235.87 Million (operating CF CN¥-60.52 Million minus capex CN¥296.38 Million) represents 1% of total liabilities (CN¥192.87 Million). Check 301281 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

1.22x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥235.87 Million
Operating CF − Capex

Total Liabilities

CN¥192.87 Million
CNY

Capital Expenditures

CN¥296.38 Million
CNY

Shandong Keyuan Pharmaceutical Co. Ltd. A Financial Flexibility Index (2021–2024)

Historical Financial Flexibility Index trend for Shandong Keyuan Pharmaceutical Co. Ltd. A across 4 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Shandong Keyuan Pharmaceutical Co. Ltd. .

Annual Financial Flexibility Index for Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)

Year-by-year free cash flow to debt coverage for Shandong Keyuan Pharmaceutical Co. Ltd. A. Explore Shandong Keyuan Pharmaceutical Co. Ltd. (301281) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2024 1.22x CN¥235.87 Million CN¥-60.52 Million CN¥192.87 Million ▲ +58.5%
2023 0.77x CN¥107.18 Million CN¥37.03 Million CN¥138.93 Million ▼ -30.7%
2022 1.11x CN¥146.97 Million CN¥115.86 Million CN¥132.06 Million ▲ +98.1%
2021 0.56x CN¥72.22 Million CN¥52.02 Million CN¥128.52 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities